Published in Antimicrob Agents Chemother on August 01, 1984
Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1987) 4.96
Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother (1989) 4.53
Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrob Agents Chemother (1987) 3.56
Characterization of the nonenzymatic chloramphenicol resistance (cmlA) gene of the In4 integron of Tn1696: similarity of the product to transmembrane transport proteins. J Bacteriol (1991) 3.53
Emergence of resistance to imipenem in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1987) 2.44
Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain length. J Bacteriol (1988) 2.35
Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin. Antimicrob Agents Chemother (1989) 2.17
Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Antimicrob Agents Chemother (1989) 2.05
Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1989) 1.58
Analysis of a common-antigen lipopolysaccharide from Pseudomonas aeruginosa. J Bacteriol (1989) 1.53
Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1990) 1.40
Broad-host-range gyrase A gene probe. Antimicrob Agents Chemother (1990) 1.38
Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob Agents Chemother (2010) 1.35
Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 1.24
Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates. Antimicrob Agents Chemother (1988) 1.20
Lipopolysaccharide-free Escherichia coli OmpF and Pseudomonas aeruginosa protein P porins are functionally active in lipid bilayer membranes. J Bacteriol (1986) 1.19
Distribution of porin and lipopolysaccharide antigens on a Pseudomonas aeruginosa permeability mutant. Antimicrob Agents Chemother (1986) 1.19
Penetration of beta-lactams through Pseudomonas aeruginosa porin channels. Antimicrob Agents Chemother (1987) 1.12
Mutation of Salmonella paratyphi A conferring cross-resistance to several groups of antibiotics by decreased permeability and loss of invasiveness. Antimicrob Agents Chemother (1988) 1.03
Outer membrane and porin characteristics of Serratia marcescens grown in vitro and in rat intraperitoneal diffusion chambers. Infect Immun (1990) 1.02
Cloning and expression in Escherichia coli of a gene encoding nonenzymatic chloramphenicol resistance from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 1.01
Growth-dependent alterations in production of serotype-specific and common antigen lipopolysaccharides in Pseudomonas aeruginosa PAO1. Infect Immun (1990) 0.97
Role of beta-lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis. Antimicrob Agents Chemother (1987) 0.96
Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams. Antimicrob Agents Chemother (1984) 0.95
Pseudomonas aeruginosa variants isolated from patients with cystic fibrosis are killed by a bactericidal protein from human polymorphonuclear leukocytes. Infect Immun (1991) 0.91
Acquisition of heme iron by Neisseria meningitidis does not involve meningococcal transferrin-binding proteins. Infect Immun (1994) 0.82
Deletion of the β-acetoacetyl synthase FabY in Pseudomonas aeruginosa induces hypoacylation of lipopolysaccharide and increases antimicrobial susceptibility. Antimicrob Agents Chemother (2013) 0.78
Cell surface changes in Pseudomonas aeruginosa PAO4069 in response to treatment with 6-aminopenicillanic acid. Antimicrob Agents Chemother (1989) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Acetylornithinase of Escherichia coli: partial purification and some properties. J Biol Chem (1956) 93.84
Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol (1973) 33.51
The outer membrane of Gram-negative bacteria. Adv Microb Physiol (1979) 7.72
Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics. Antimicrob Agents Chemother (1977) 7.70
A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal Biochem (1978) 7.69
Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier. J Bacteriol (1978) 7.66
R factor variants with enhanced sex factor activity in Pseudomonas aeruginosa. Mol Gen Genet (1976) 7.44
Porin channels in Escherichia coli: studies with beta-lactams in intact cells. J Bacteriol (1983) 6.29
Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob Agents Chemother (1982) 4.98
Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J Bacteriol (1980) 4.93
Effect on solute size on diffusion rates through the transmembrane pores of the outer membrane of Escherichia coli. J Gen Physiol (1981) 3.72
Identification of the protein producing transmembrane diffusion pores in the outer membrane of Pseudomonas aeruginosa PA01. Biochim Biophys Acta (1979) 3.70
Procedure for determining heptose and hexose in lipopolysaccharides. Modification of the cysteine-sulfuric acid method. Anal Biochem (1972) 3.35
Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant. J Bacteriol (1983) 2.98
Chemical and chromatographic analysis of lipopolysaccharide from an antibiotic-supersusceptible mutant of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 2.64
Penetration of beta-lactam antibiotics into their target enzymes in Pseudomonas aeruginosa: comparison of a highly sensitive mutant with its parent strain. Antimicrob Agents Chemother (1980) 2.48
Studies of lipopolysaccharides from Pseudomonas aeruginosa. Eur J Biochem (1975) 2.39
Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics. Int J Clin Pharmacol Biopharm (1979) 2.07
beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment. Antimicrob Agents Chemother (1981) 1.82
Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins. Antimicrob Agents Chemother (1981) 1.66
O-antigen conversion in Pseudomonas aeruginosa PAO1 by bacteriophage D3. J Bacteriol (1983) 1.47
Resistance of Pseudomonas aeruginosa to antimicrobial drugs. Prog Med Chem (1975) 1.42
Partition data of penicillins determined by means of reversed-phase thin-layer chromatography. J Chromatogr (1969) 1.10
Correlation between pyocin-sensitivity and 2-amino sugar composition of Pseudomonas aeruginosa. FEBS Lett (1974) 1.05
Fluorometric analysis of amino sugars and derivatized neutral sugars. Anal Biochem (1982) 1.00
Mutation of Pseudomonas aeruginosa specifying reduced affinity for penicillin G. Antimicrob Agents Chemother (1982) 0.94
Fluorometric analysis of polyamines, histamine, and 1-methylhistamine. Anal Biochem (1979) 0.93
Carbenicillin resistance of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 0.84
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med (1984) 6.54
Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother (1977) 4.11
Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol (1991) 3.13
Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 3.01
Transferable drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1972) 2.83
Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics. Antimicrob Agents Chemother (1984) 2.65
Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother (1983) 2.58
Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates. Antimicrob Agents Chemother (1994) 2.47
Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain length. J Bacteriol (1988) 2.35
Accumulation of enoxacin by Escherichia coli and Bacillus subtilis. Antimicrob Agents Chemother (1987) 2.26
Characteristics of R931 and other Pseudomonas aeruginosa R factors. Antimicrob Agents Chemother (1973) 2.24
Gentamicin accumulation by sensitive strains of Escherichia coli and Pseudomonas aeruginosa. J Antibiot (Tokyo) (1975) 2.21
Transferable chloramphenicol and ampicillin resistance in a strain of Haemophilus influenzae. Antimicrob Agents Chemother (1978) 2.18
Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrob Agents Chemother (1979) 2.16
Gentamicin resistance in Pseudomonas aeruginosa: R-factor-mediated resistance. Antimicrob Agents Chemother (1974) 2.13
Comparison of a slide blood culture system with a supplemented peptone broth culture method. J Clin Microbiol (1981) 2.12
Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Antimicrob Agents Chemother (1989) 2.05
Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun (1995) 2.05
Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother (1995) 1.94
In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement. J Infect Dis (1991) 1.90
Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 1.88
Effect of enzymatic adenylylation on dihydrostreptomycin accumulation in Escherichia coli carrying an R-factor: model explaining aminoglycoside resistance by inactivating mechanisms. Antimicrob Agents Chemother (1978) 1.86
beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment. Antimicrob Agents Chemother (1981) 1.82
Further properties of P-2 R-factors of Pseudomonas aeruginosa and their relationship to other plasmid groups. Can J Microbiol (1975) 1.79
Mechanisms and spectrum of streptomycin resistance in a natural population of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1972) 1.78
Penicillin-binding components of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother (1980) 1.72
Aminoglycoside-resistant mutation of Pseudomonas aeruginosa defective in cytochrome c552 and nitrate reductase. Antimicrob Agents Chemother (1980) 1.69
Ribotype analysis of Pseudomonas pseudomallei isolates. J Clin Microbiol (1993) 1.52
Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification. J Antibiot (Tokyo) (1976) 1.47
Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency. J Antimicrob Chemother (1990) 1.45
Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance. Antimicrob Agents Chemother (1986) 1.41
Latex agglutination test for detection of Clostridium difficile toxin in stool samples. J Clin Microbiol (1984) 1.39
Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay. J Clin Microbiol (1983) 1.39
Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase. Antimicrob Agents Chemother (1991) 1.37
Categorization of clinical isolates of Helicobacter pylori on the basis of restriction digest analyses of polymerase chain reaction-amplified ureC genes. J Clin Microbiol (1993) 1.36
Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrite reductase, and aerobic transport. Antimicrob Agents Chemother (1981) 1.27
Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy. Antimicrob Agents Chemother (1991) 1.24
Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals. J Infect Dis (1985) 1.23
Classification of R plasmids by incompatibility in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 1.23
Distribution of porin and lipopolysaccharide antigens on a Pseudomonas aeruginosa permeability mutant. Antimicrob Agents Chemother (1986) 1.19
Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect Immun (1997) 1.18
Mechanisms of aminoglycoside resistance of anaerobic bacteria and facultative bacteria grown anaerobically. J Antimicrob Chemother (1981) 1.15
Cloning and expression of genes responsible for altered penicillin-binding proteins 3a and 3b in Haemophilus influenzae. Antimicrob Agents Chemother (1987) 1.15
Transformation of Pseudomonas aeruginosa by electroporation. Anal Biochem (1990) 1.14
Lipopolysaccharide composition of three strains of Haemophilus influenzae. Can J Microbiol (1984) 1.14
Penetration of beta-lactams through Pseudomonas aeruginosa porin channels. Antimicrob Agents Chemother (1987) 1.12
Resistance of Pseudomonas aeruginosa mutants with altered control of chromosomal beta-lactamase to piperacillin, ceftazidime, and cefsulodin. Antimicrob Agents Chemother (1984) 1.11
Characteristics of PR5, a lipid-containing plasmid-dependent phage. Can J Microbiol (1978) 1.11
Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin. Antimicrob Agents Chemother (1989) 1.08
DNA probe technology for rapid detection of Haemophilus influenzae in clinical specimens. J Clin Microbiol (1988) 1.08
The effect of complement and other cell wall reagents on tetracycline and streptomycin resistance in Pseudomonas aeruginosa. Can J Microbiol (1974) 1.06
Haemophilus influenzae penicillin-binding proteins 1a and 3 possess distinct and opposite temperature-modulated penicillin-binding activities. Antimicrob Agents Chemother (1988) 1.04
Relationship between gentamicin susceptiblity criteria and therapeutic serum levels for Pseudomonas aeruginosa in mouse infection model. Antimicrob Agents Chemother (1978) 1.02
Virulence of Pseudomonas aeruginosa strains with mechanisms of microbial persistence for beta-lactam and aminoglycoside antibiotics in a mouse infection model. Can J Microbiol (1985) 1.00
Mechanisms of R factor R931 and chromosomal tetracycline resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1973) 1.00
Lipopolysaccharide banding patterns of Neisseria meningitidis and Neisseria gonorrhoeae. J Clin Microbiol (1984) 0.98
Metronidazole uptake in Helicobacter pylori. Can J Microbiol (1995) 0.97
Immunological cross-reactivity of a Mycoplasma pneumoniae membrane-associated protein antigen with Mycoplasma genitalium and Acholeplasma laidlawii. J Clin Microbiol (1987) 0.97
Immune response of the mouse to gram-negative bacterial outer membrane extracts as assessed with monoclonal antibodies. J Immunol (1982) 0.96
Interaction of the fluoroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes. Antimicrob Agents Chemother (1989) 0.95
Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams. Antimicrob Agents Chemother (1984) 0.95
Simple screening method for beta-lactamase-positive and -negative ampicillin-resistant Haemophilus influenzae isolates. J Clin Microbiol (1984) 0.94
Mutation of Pseudomonas aeruginosa specifying reduced affinity for penicillin G. Antimicrob Agents Chemother (1982) 0.94
Identification of a group of Haemophilus influenzae penicillin-binding proteins that may have complementary physiological roles. Antimicrob Agents Chemother (1990) 0.91
Infection of the skin by Mycobacterium marinum: report of five cases. Can Med Assoc J (1977) 0.89
Enzyme-linked immunosorbent assay compared with immunoprecipitation for serotyping Neisseria meningitidis and its use in demonstrating serotype polymorphism. J Clin Microbiol (1981) 0.89
Ferredoxin-linked reduction of metronidazole in Clostridium pasteurianum. Antimicrob Agents Chemother (1984) 0.88
DNA probe technology for detection of Haemophilus influenzae. Mol Cell Probes (1987) 0.88
Antigenic relationships among penicillin-binding proteins 1 from members of the families Pasteurellaceae and Enterobacteriaceae. Antimicrob Agents Chemother (1986) 0.88
Interaction of Clostridium difficile toxin A with L cells in culture. Can J Microbiol (1984) 0.87
Mechanism of Pseudomonas aeruginosa persistence during treatment with broad-spectrum cephalosporins of lung infections in patients with cystic fibrosis. Antimicrob Agents Chemother (1987) 0.87
Identification and comparative analysis of the lactoferrin and transferrin receptors among clinical isolates of gonococci. J Med Microbiol (1989) 0.87
Immunoblot analysis of serologic response to outer membrane proteins of Escherichia coli in elderly individuals with urinary tract infections. J Clin Microbiol (1988) 0.86
Correlation of Pseudomonas aeruginosa virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse. Can J Microbiol (1997) 0.84
Penicillin-binding proteins of Haemophilus ducreyi. Antimicrob Agents Chemother (1989) 0.83
Pre-boiling high GC content, mixed primers with 3' complementation allows the successful PCR amplification of Pseudomonas aeruginosa DNA. Nucleic Acids Res (1992) 0.82
A study of the ultrastructure of visual cell outer segment membranes. J Ultrastruct Res (1973) 0.80
Culture-amplified immunological detection of Mycoplasma pneumoniae in clinical specimens. Diagn Microbiol Infect Dis (1988) 0.79
Decreased susceptibility of Serratia marcescens to chlorhexidine related to the inner membrane. J Antimicrob Chemother (1985) 0.78
Gentamicin and albumin-bilirubin binding. An in vivo study. J Pediatr (1976) 0.78
Possible mechanisms in the pathogenesis of virus-induced diabetes mellitus. Clin Invest Med (1987) 0.78
Antibody-coated bacteria in the urine of preschool and school-aged girls with asymptomatic bacteriuria. Can Med Assoc J (1976) 0.78
A strong, specific response of mice to serotype-specific antigenic determinants of Neisseria meningitidis, analyzed with mouse monoclonal antibodies. J Immunol (1981) 0.77
Antibiotic uptake and the cytoplasmic membrane. Antibiot Chemother (1971) (1985) 0.77
Enzyme immunoaffinity chromatography--a rapid semi-quantitative immunoassay technique for screening the presence of isoproturon in water samples. Analyst (1997) 0.76
Structural instability of IncP-1 plasmids in Pseudomonas aeruginosa PAT involves interaction with plasmid pVS1. J Bacteriol (1980) 0.75
Cell surface changes in Pseudomonas aeruginosa PAO4069 in response to treatment with 6-aminopenicillanic acid. Antimicrob Agents Chemother (1989) 0.75
Purification, modification during purification, and characterization of a deoxyribonuclease from Pseudomonas aeruginosa. J Biol Chem (1972) 0.75
Lack of protection against ascending Escherichia coli pyelonephritis in diabetic rats following immunization with purified lipopolysaccharide. Can J Microbiol (1986) 0.75
[Analysis of lipopolysaccharide (LPS) from impermeability-type drug resistant Pseudomonas aeruginosa using new, highly-sensitive LPS staining method]. Jpn J Antibiot (1994) 0.75